| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/01/2008 | US20080103124 Cefdinir-containing pharmaceutical composition |
| 05/01/2008 | US20080103115 Phosphonate compounds |
| 05/01/2008 | US20080103109 Distributing polynucleotide in vivo using conditional vector that is transcriptionally active in normal cells and not in malfunctioning cells |
| 05/01/2008 | US20080103108 Targeted artificial gene delivery |
| 05/01/2008 | US20080103101 Ku-70-derived bax-suppressing peptides and use thereof for the protection of damaged cells |
| 05/01/2008 | US20080103099 Apoptin-associating protein |
| 05/01/2008 | US20080103098 Recombinant Expression of Proteins in a Disulfide-Bridged, Two-Chain Form |
| 05/01/2008 | US20080102142 Method of using ajoene as alcohol dehydrogenase inhibitor, composition for removing hangover comprising ajoene and method of preparing the same |
| 05/01/2008 | US20080102138 Increasing serotonin levels; utilizing tryptophan or 5-hydroxy derivative; treatment of detrimental health effects caused by loss of vital body substances such as vitamins, minerals, amino acids, co-factors and neurotransmitters which result from tobacco smoking |
| 05/01/2008 | US20080102136 Reactive nanoparticles as destructive adsorbents for biological and chemical contamination |
| 05/01/2008 | US20080102128 formed of amphiphilic polyamino acids which transport active principle(s), AP(s), in particular protein and peptide active principle(s) |
| 05/01/2008 | US20080102125 For increasing plasma concentration of insulin-like growth factor-1; oximination with polyoxyethylene glycol |
| 05/01/2008 | US20080102124 Modified Human Growth Hormone |
| 05/01/2008 | US20080102117 Base material for dry direct tableting comprising low-substituted hydroxypropyl cellulose |
| 05/01/2008 | US20080102113 capsules encapsulate a drug, such that the number of capsules needed to be ingested to cause emesis is fewer than the number of capsules needed to be ingested to cause overdose of the drug, so that if a person takes an overdose of the emetic encapsulated drug, he or she will vomit before drug absorbed |
| 05/01/2008 | US20080102106 Wound Healing Composition Comprising Substances From Diptera Larvae |
| 05/01/2008 | US20080102104 formed of copolyesters of polycaprolactone or a copolyester of epsilon -caprolactone and at least one cyclic monomer selected from the group consisting of lactide, glycolide and trimethylene carbonate |
| 05/01/2008 | US20080102092 Animal extract from scallop shells; grinding, crystal structure; skin disorders |
| 05/01/2008 | US20080102088 against tularemia; subcellular protein expressed from Francisella tularensis infected mammal subculture growing in synthetic salts medium of weak acidity |
| 05/01/2008 | US20080102085 Vaccines for treatment of Aids; protein or polynucleotide is delivered via a bombardment approach |
| 05/01/2008 | US20080102084 Anti-cancer DNA Vaccine Employing Plasmids Encoding Mutant Oncoprotein Antigen and Calreticulin |
| 05/01/2008 | US20080102083 Compositions and Methods for the Preparation of Human Growth Hormone Glycosylation Mutants |
| 05/01/2008 | US20080102082 Policosanols and red yeast combined with astaxanthin and/or folic acid; antioxidant and antihypercholesterolemia activity |
| 05/01/2008 | US20080102080 Fusion proteins comprising hiv-1 tat and/or nef proteins |
| 05/01/2008 | US20080102079 Poultry Vaccine, for Necrotic Enteritis, Comprising a Mutated Clostridium Perfringens Alpha Toxin Antigen, and Methods of Producing the Vaccine |
| 05/01/2008 | US20080102078 Mutated e. coli heat-labile enterotoxin |
| 05/01/2008 | US20080102077 Nucleic and Protein Sequences from the Hxhv Virus and Uses Thereof |
| 05/01/2008 | US20080102076 Immunostimulatory Compositions and Uses Thereof |
| 05/01/2008 | US20080102074 Comprises selenium, copper, zinc, manganese and/or chromium, and EDTA |
| 05/01/2008 | US20080102072 Cytokine specific immunoglobulin for prevention and treatment of diabetes, autoimmune and inflammatory disorders |
| 05/01/2008 | US20080102071 T cell inhibitory receptor compositions and uses thereof |
| 05/01/2008 | US20080102070 SCDs As Modifiers of the p53 Pathway and Methods of Use |
| 05/01/2008 | US20080102066 Ultrapure transferrin for pharmaceutical compositions |
| 05/01/2008 | US20080102064 Mixture comprising blood coagulation factor and serpin for use in prevention and treatment of blood disorders |
| 05/01/2008 | US20080102063 Inducing mesenchymal, adipose-derived or hematopoietic progenitor cells to differentiate into autoimmune T-cells for use in treatment of nervous system disorders |
| 05/01/2008 | US20080102060 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 05/01/2008 | US20080102058 Stromal cell use |
| 05/01/2008 | US20080102057 Bipotential liver cell lines from wild-type mammalian liver tissue |
| 05/01/2008 | US20080102051 Use of polyols to increase stiffness in low voc hair styling products |
| 05/01/2008 | US20080102036 Biocompatible Fluorescent Silicon Nanoparticles |
| 05/01/2008 | US20080102034 Antihyperplastic agent preparation applicable to angiography catheter; enhancing artery and/or vein imaging; side effect reduction; rapid, efficient absorption through capillary walls |
| 05/01/2008 | US20080102033 Antihyperplastic agent preparation applicable to angiography catheter; enhancing artery and/or vein imaging; side effect reduction; rapid, efficient absorption through capillary walls |
| 05/01/2008 | US20080102030 Particles for cell targeting |
| 05/01/2008 | US20080102027 Targer For B-Cell Disorders |
| 04/30/2008 | EP1916307A1 Plant enzymes for bioconversion |
| 04/30/2008 | EP1916247A1 Activator of peroxisome proliferator activated receptor |
| 04/30/2008 | EP1916245A1 Indole derivative having pgd2 receptor antagonist activity |
| 04/30/2008 | EP1916241A1 Crystal of phenylalanine derivative, process for producing the same and use thereof |
| 04/30/2008 | EP1916234A1 Cyclopropanecarboxylic acid compound |
| 04/30/2008 | EP1916001A2 Human antibodies specific to KDR and uses thereof |
| 04/30/2008 | EP1915993A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 04/30/2008 | EP1915992A1 Use of cyclooxygenase inhibitors and antimuscarinic agents for the treatment of incontinence |
| 04/30/2008 | EP1915144A2 Method to reduce oxidative damage and improve mitochondrial efficiency |
| 04/30/2008 | EP1531805B1 Composition devoid of ascorbic acid comprising a cholesterol absorption inhibitor, an hmg-coa reductase inhibitor and a stabilizing agent |
| 04/30/2008 | EP1425381B1 Emu-based formulations for wound treatment related application information |
| 04/30/2008 | EP1399023B1 COMPOSITIONS FOR SYSTEMIC ADMINISTRATION OF SEQUENCES ENCODING BONE MORPHOGENETIC PROTEINS& x9; |
| 04/30/2008 | EP1212063B9 Topical azathioprine for the treatment of oral autoimmune diseases |
| 04/30/2008 | EP1208116B1 Somatostatin analogs, radiolabelled derivatives thereof and their use |
| 04/30/2008 | EP1165613B1 Melanocortin receptor ligands |
| 04/30/2008 | EP1058728B1 V-like domain binding molecules |
| 04/30/2008 | EP0730657B1 Composition for the in vivo production of therapeutic products |
| 04/30/2008 | CN101171266A Acerola fruit-derived pectin and use thereof |
| 04/30/2008 | CN101171249A Method for producing indole derivative having piperidine ring |
| 04/30/2008 | CN101171019A Immune function modulating agents |
| 04/30/2008 | CN101167974A Quality control method of 'xuhanting' preparation |
| 04/30/2008 | CN101167891A Medicinal injection for treating strawberry shape and spongiform angioma |
| 04/30/2008 | CN101167774A Ginseng and American ginseng different parts extraction and its application for poultry and livestock |
| 04/30/2008 | CN101167709A Compound methylephedrine capsule and preparation method thereof |
| 04/30/2008 | CN100385005C Methods for the production of multimeric proteins, and related compositions |
| 04/30/2008 | CN100385002C Di- or oligomer of a dimer, trimer, quatrometer or pentamer of recombinant fusion proteins |
| 04/30/2008 | CN100384880C Modified peptides as therapeutic agents |
| 04/30/2008 | CN100384879C Modified peptides as therapeutic agents |
| 04/30/2008 | CN100384852C Heterocyclic amide derivatives as inhibitors of glycogen phoshorylase |
| 04/30/2008 | CN100384847C Adenosine a2a receptor antagonists |
| 04/30/2008 | CN100384837C Novel farnesyl protein transferase inhibitors as antitumor |
| 04/30/2008 | CN100384836C Novel cyclic amide derivatives |
| 04/30/2008 | CN100384834C Epothilone derivatives |
| 04/30/2008 | CN100384833C Therapeutic chroman compounds |
| 04/30/2008 | CN100384825C Benzheterocyclic derivatives |
| 04/30/2008 | CN100384823C Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 04/30/2008 | CN100384821C Cetp activity inhibitors |
| 04/30/2008 | CN100384820C Phosphate prodrugs of fluorooxindoles |
| 04/30/2008 | CN100384472C Antigen-specific lgE antibody production inhibitors |
| 04/30/2008 | CN100384471C Albumin solution and method for the production thereof |
| 04/30/2008 | CN100384461C Anoxia resisting pharmaceutical composition and its preparation method |
| 04/30/2008 | CN100384433C Remedies |
| 04/30/2008 | CN100384430C Combination therepy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 04/30/2008 | CN100384424C Synergistic methods and compositions for treating cancer |
| 04/30/2008 | CN100384418C Isoxazolopyridinones and use thereof in the treatment of parkinson's disease |
| 04/30/2008 | CN100384417C Pyranoindazoles and their use for the treatment of glaucoma |
| 04/30/2008 | CN100384413C Combination of selected opioids with muscarine antagonists for treating urinary incontinence |
| 04/30/2008 | CN100384412C Methods and compositions for inhibiting 5 'alpha'-reductase activity |
| 04/30/2008 | CN100384400C Small golden pellets and preparation method |
| 04/30/2008 | CN100384347C Food mother material and its making method |
| 04/29/2008 | US7365216 Process for the production of citalopram |
| 04/29/2008 | US7365196 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 04/29/2008 | US7365172 Cytoprotective agent to protect a patient undergoing cancer cytotoxic therapy from gastrointestinal side effects; peptide that is derived from a loop or "lollipop" region of transforming growth factor; stimulate hematopoiesis; diabetes, rheumatoid arthritis, lupus, and multiple sclerosis |
| 04/29/2008 | US7365170 Reagents for regulation of metabolic events, such as those mediated by adiponectin and adiponectin agonists. The invention also provides screening assays for identification of biologically active agents, diagnostic and therapeutic agents |
| 04/29/2008 | US7365159 Plasminogen fragments containing kringle region domains having anti-angiogenic activity and terned angiostatin protein. The plasminogen fragments of the present invention may be used for the treatment of angiogenesis-dependent diseases such as |
| 04/29/2008 | US7365155 Immunoregulator |